TC BioPharm (Holdings) PLC (TCBP)
0.62
-0.01
(-1.56%)
USD |
NASDAQ |
Nov 22, 09:37
TC BioPharm Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2021 | 0.6668M |
| September 30, 2021 | 0.682M |
| Date | Value |
|---|---|
| December 31, 2020 | 0.6527M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.6527M
Minimum
Dec 2020
0.682M
Maximum
Sep 2021
0.6672M
Average
0.6668M
Median
Dec 2021
Revenue (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 40.90M |
| Biodexa Pharmaceuticals PLC | -- |
| Verona Pharma PLC | 5.624M |
| NuCana PLC | -- |
| Autolus Therapeutics PLC | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.213M |
| Total Expenses (Quarterly) | 4.365M |
| EPS Diluted (Quarterly) | -27.90 |
| Enterprise Value | -0.927M |
| Earnings Yield | -444.4K% |